MarketCap
ACADIA Pharmaceuticals ACAD
$ 18.13
13.1%
Facebook
X
Telegram
ACADIA Pharmaceuticals EV/EBITDA Ratio | ACAD
Annual EV/EBITDA Ratio ACADIA Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 36 | 14.4 | -45.7 | -13.5 | -21.1 | -25.5 | -23.4 | -11.3 | -12.7 | -13.3 | -12.1 | -31.1 | -53.1 | -13.5 | -3.23 | 3.39 | -1.26 | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 36 | -53.1 | -13.4 |
EV/EBITDA Ratio of other stocks in the Biotechnology industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
PainReform Ltd.
PRFX
|
-0.255 | $ 0.78 | -4.24 % | $ 505 K |  Israel |
 |
Prothena Corporation plc
PRTA
|
0.0485 | $ 8.56 | -2.51 % | $ 461 M |  USA |
 |
Arcus Biosciences
RCUS
|
-5.18 | $ 18.66 | -1.56 % | $ 2 B | USA |
 |
Orgenesis
ORGS
|
-1.03 | - | -33.86 % | $ 61.2 M | USA |
 |
Dr. Reddy's Laboratories Limited
RDY
|
2.14 | $ 14.9 | -1.03 % | $ 12.4 B |  India |
 |
Regeneron Pharmaceuticals
REGN
|
21.2 | $ 916.16 | -0.41 % | $ 95.8 B | USA |
 |
Replimune Group
REPL
|
-3.15 | $ 23.3 | 4.67 % | $ 2.16 B | USA |
 |
Фармсинтез
LIFE
|
-115 | - | - | - |  Russia |
 |
Royalty Pharma plc
RPRX
|
18.1 | $ 69.47 | 1.02 % | $ 29.9 B | USA |
 |
Revolution Medicines
RVMD
|
-17 | $ 193.0 | -3.57 % | $ 36.7 B | USA |
 |
Rhythm Pharmaceuticals
RYTM
|
-33.9 | $ 113.99 | 0.04 % | $ 7.41 B | USA |
 |
Codiak BioSciences
CDAK
|
-4.42 | - | -55.98 % | $ 2.15 M | USA |
 |
Sana Biotechnology
SANA
|
-4.97 | $ 2.43 | -1.42 % | $ 615 M | USA |
 |
Sol-Gel Technologies Ltd.
SLGL
|
-26.8 | $ 61.81 | 0.11 % | $ 172 M | Israel |
 |
Summit Therapeutics
SMMT
|
81.3 K | $ 17.78 | -0.34 % | $ 13.3 B |  Britain |
 |
Checkpoint Therapeutics
CKPT
|
-3.09 | - | - | $ 169 M | USA |
 |
Syndax Pharmaceuticals
SNDX
|
-7.7 | $ 9.43 | -0.89 % | $ 817 M | USA |
 |
Spero Therapeutics
SPRO
|
16.2 | $ 1.01 | -5.61 % | $ 56.6 M | USA |
 |
Sarepta Therapeutics
SRPT
|
-4.66 | $ 16.4 | -5.54 % | $ 1.64 B | USA |
 |
Tarsus Pharmaceuticals
TARS
|
-42.1 | $ 73.9 | 4.32 % | $ 3.09 B | USA |
 |
Bio-Techne Corporation
TECH
|
31.6 | $ 72.83 | -0.01 % | $ 11.4 B | USA |
 |
Sage Therapeutics
SAGE
|
-1.01 | - | - | $ 527 M | USA |
 |
Taro Pharmaceutical Industries Ltd.
TARO
|
5.02 | - | - | $ 1.62 B | Israel |
 |
Cabaletta Bio
CABA
|
-1.49 | $ 1.43 | -5.0 % | $ 144 M | USA |
 |
Forma Therapeutics Holdings
FMTX
|
-2.62 | - | - | $ 958 M | USA |
 |
Blueprint Medicines Corporation
BPMC
|
414 | - | - | $ 8.14 B | USA |
 |
Horizon Therapeutics Public Limited Company
HZNP
|
22.7 | - | - | $ 26.6 B |  Irlanda |
 |
Tonix Pharmaceuticals Holding Corp.
TNXP
|
0.497 | $ 4.12 | -8.35 % | $ 35.1 M | USA |
 |
Paratek Pharmaceuticals
PRTK
|
-8.54 | - | - | $ 121 M | USA |
 |
DBV Technologies S.A.
DBVT
|
-18.7 | $ 11.55 | 4.52 % | $ 1.61 B |  France |
 |
Gilead Sciences
GILD
|
16.9 | $ 170.68 | 0.8 % | $ 212 B | USA |
 |
Taysha Gene Therapies
TSHA
|
-11.3 | $ 4.28 | -2.06 % | $ 1.37 B | USA |
 |
ASLAN Pharmaceuticals Limited
ASLN
|
-0.381 | - | -14.27 % | $ 1.7 M |  Singapore |
 |
Adverum Biotechnologies
ADVM
|
-0.921 | - | - | $ 86.2 M | USA |
 |
Unity Biotechnology
UBX
|
-1.71 | - | -33.41 % | $ 3.37 M | USA |
 |
iTeos Therapeutics
ITOS
|
-1.56 | - | - | $ 411 M | USA |
 |
Gossamer Bio
GOSS
|
-2.14 | $ 11.2 | 5.21 % | $ 2.56 B | USA |
 |
GeoVax Labs
GOVX
|
-0.0305 | $ 0.11 | -22.17 % | $ 105 K | USA |
 |
United Therapeutics Corporation
UTHR
|
14.4 | $ 588.33 | 1.01 % | $ 26.1 B | USA |
 |
Seelos Therapeutics
SEEL
|
-1.02 | - | -47.76 % | $ 6.27 M | USA |
 |
Vericel Corporation
VCEL
|
84.9 | $ 59.02 | 1.08 % | $ 2.97 B | USA |
 |
Veracyte
VCYT
|
35.1 | $ 24.05 | -7.21 % | $ 1.89 B | USA |
 |
Advaxis
ADXS
|
0.084 | - | -9.65 % | $ 45.9 M | USA |
 |
GlaxoSmithKline plc
GSK
|
32.5 | $ 51.25 | -0.56 % | $ 208 B | Britain |
 |
Vir Biotechnology
VIR
|
-2.19 | $ 13.17 | -3.48 % | $ 1.82 B | USA |
 |
Viking Therapeutics
VKTX
|
-7.87 | $ 28.67 | -1.1 % | $ 3.23 B | USA |
 |
Vanda Pharmaceuticals
VNDA
|
-2.9 | $ 4.07 | -0.49 % | $ 240 M | USA |
 |
Verrica Pharmaceuticals
VRCA
|
-4.89 | $ 3.55 | -1.11 % | $ 37.8 M | USA |
 |
Vertex Pharmaceuticals Incorporated
VRTX
|
29 | $ 547.74 | -0.57 % | $ 140 B | USA |
 |
Kiromic BioPharma
KRBP
|
-1.15 | - | 6.61 % | $ 3.08 M | USA |